- Active Pharmaceutical Ingredients
- Varenicline tartrate
- Aprepitant, Fosapitant Intermediates
- Fosaprepitant Dimeglumine
- Vildagliptin
- Efinaconazole
- Luliconazole Intermediate
- Gadoterate Meglumine
- Succinyl Alcohol Intermediate
- Mirabillon Intermediate
- Atazanavir Intermediate
- Intermediate
- Varenicline tartrate 230615-70-0
- Aprepitant 287930-73-8
- Aprepitant 127852-28-2
- Aprepitant 287930-75-0
- Aprepitant 200000-59-5
- Aprepitant 155742-64-6
- Aprepitant 252742-72-6
- Fosaprepitant Dimeglumine 990-91-0
- Fosaprepitant Dimeglumine 265121-01-5
- Vildagliptin 207557-35-5
- Vildagliptin 702-82-9
- Efinaconazole 144230-50-2
- Efinaconazole 133775-25-4
- Efinaconazole 127000-90-2
- Gadoterate Meglumine
- Mirabegron
- Luliconazole 98873-55-3
- Luliconazole 126534-31-4
- Atazanavir sulfate
- Bortezomib 179324-87-9
- Bortezomib 114457-94-2
- Bortezomib 205393-22-2
- Brinzolamide
- Rivaroxaban Intermediate 446292-08-6
- Rivaroxaban Intermediate 446292-07-5
- Cinacalcet Hydrochloride 1005450-55-4
- Cinacalcet Hydrochloride 585-50-2
- Eletriptan Intermediate
- Indacaterol intermediate 312753-53-0
- Indacaterol intermediate 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
Popular information
Painkiller Eletriptan Hydrobromide 177834-92-3
【Catalog Number】AP0703
【CAS #】 177834-92-3
【Molecular Formula】C22H27BrN2O2S
【Molecular Weight】463.43
|
Alias |
Elertriptan Hydrobromide; (R) -3-[(1-methyl-2-pyrrolidinyl) methyl] -5- [2- (benzenesulfonyl) ethyl] -1H-indole Hydrobromide |
|
Catalog Number |
AP0703 |
|
CAS # |
177834-92-3 |
|
Molecular Formula |
C22H27BrN2O2S |
|
Molecular Weight |
463.43 |
|
Structural Formula |
|
|
Product Introduction CAS 177834-92-3 US-DMF No. 27069 |
Eletriptan hydrobromide, English name is Eletriptan hydrobromide, American Chemical Abstracts Registration Number is cas 177834-92-3. Eletriptan hydrobromide (cas 177834-92-3) is a selective 5-HT receptor agonist that stimulates intracranial blood vessels (including arteriovenous anastomosis) and sympathetic nerves of the trigeminal nervous system5 -HTIB / ID receptor, which causes intracranial vasoconstriction and inhibits the release of pro-inflammatory neuropeptides. For the treatment of adult aura or non-aura migraine. |
VIWIT 沪ICP备12014533号-2
